T1	chemical 15 25	inhibitors
T2	chemical 35 38	MYC
T3	disease_or_phenotypic_feature 101 113	osteosarcoma
T4	chemical 115 130	Hyaluronic acid
T5	chemical 143 154	biochemical
T6	disease_or_phenotypic_feature 182 197	biliary atresia
T7	chemical 304 314	biological
T8	disease_or_phenotypic_feature 375 388	breast cancer
T9	chemical 407 416	oxidative
T10	disease_or_phenotypic_feature 427 434	obesity
T11	disease_or_phenotypic_feature 443 457	glomerulopathy
T12	disease_or_phenotypic_feature 537 550	growth delays
T13	chemical 587 597	inhibitors
T14	chemical 606 642	5,6-dimethylxanthenone-4-acetic acid
T15	chemical 644 649	DMXAA
T16	chemical 656 666	inhibitors
T17	disease_or_phenotypic_feature 700 711	hypokalemia
T18	disease_or_phenotypic_feature 713 733	hypercholesterolemia
T19	disease_or_phenotypic_feature 735 748	hyperuricemia
T20	disease_or_phenotypic_feature 754 767	hyperglycemia
T21	chemical 769 777	Estrogen
T22	disease_or_phenotypic_feature 778 787	dependent
T23	chemical 816 825	tamoxifen
T24	disease_or_phenotypic_feature 836 849	breast cancer
T25	chemical 881 889	estrogen
T26	disease_or_phenotypic_feature 922 930	melanoma
T27	disease_or_phenotypic_feature 935 943	lymphoma
T28	chemical 1036 1045	inhibitor
T29	chemical 1055 1065	tryptophan
T30	chemical 1081 1087	oxygen
T31	disease_or_phenotypic_feature 1117 1130	breast cancer
T32	chemical 1241 1254	Linoleic acid
T33	disease_or_phenotypic_feature 1306 1314	hepatoma
T34	chemical 1330 1337	mitogen
T35	chemical 1365 1369	acid
T36	disease_or_phenotypic_feature 1381 1394	Neuroblastoma
T37	chemical 1454 1463	inhibitor
T38	chemical 1464 1475	binimetinib
T39	chemical 1535 1542	biology
T40	disease_or_phenotypic_feature 1605 1624	lung adenocarcinoma
T41	chemical 1669 1679	paclitaxel
T42	chemical 1684 1695	carboplatin
T43	chemical 1697 1700	TPA
T44	chemical 1707 1716	antigenic
T45	disease_or_phenotypic_feature 1762 1771	carcinoma
T46	chemical 1830 1838	antigens
T47	chemical 1947 1955	antigens
T48	disease_or_phenotypic_feature 1968 1979	lung cancer
T49	disease_or_phenotypic_feature 2015 2026	hypersomnia
T50	disease_or_phenotypic_feature 2094 2106	hyperthermia
T51	disease_or_phenotypic_feature 2180 2198	hyperprolactinemia
T52	disease_or_phenotypic_feature 2200 2214	hypothyroidism
T53	chemical 2220 2234	growth-hormone
T54	disease_or_phenotypic_feature 2260 2273	malabsorption
T55	chemical 2335 2344	inhibitor
T56	chemical 2345 2358	canagliflozin
T57	chemical 2360 2374	Growth hormone
T58	disease_or_phenotypic_feature 2379 2394	prostate cancer
T59	chemical 2495 2504	effectors
T60	disease_or_phenotypic_feature 2508 2514	cancer
T61	disease_or_phenotypic_feature 2516 2523	obesity
T62	disease_or_phenotypic_feature 2528 2536	diabetes
T63	disease_or_phenotypic_feature 2542 2548	autism
T64	chemical 2568 2572	drug
T65	disease_or_phenotypic_feature 2612 2625	hyperglycemia
T66	chemical 2648 2658	tacrolimus
T67	chemical 2663 2675	cyclosporine
T68	missed_disease_or_phenotypic_feature 570 575	tumor
T69	corrected_chemical 570 597	tumor blood flow inhibitors
R1	treats Arg1:T15 Arg2:T68	
R2	treats Arg1:T14 Arg2:T68	
T70	corrected_chemical 652 666	ACE inhibitors
R3	treats Arg1:T70 Arg2:T17	
R4	treats Arg1:T70 Arg2:T18	
R5	treats Arg1:T70 Arg2:T19	
T71	missed_disease_or_phenotypic_feature 788 794	tumors
R6	causes_or_contributes_to Arg1:T21 Arg2:T71	
R7	treats Arg1:T23 Arg2:T24	
T72	missed_chemical 958 965	MSC-IDO
R8	causes_or_contributes_to Arg1:T72 Arg2:T27	
R9	causes_or_contributes_to Arg1:T72 Arg2:T26	
T73	corrected_chemical 1046 1065	1-methyl-tryptophan
R10	treats Arg1:T73 Arg2:T27	
R11	treats Arg1:T73 Arg2:T26	
T74	corrected_chemical 1032 1045	IDO inhibitor
R12	treats Arg1:T74 Arg2:T27	
R13	treats Arg1:T74 Arg2:T26	
T75	missed_disease_or_phenotypic_feature 1266 1271	tumor
R14	causes_or_contributes_to Arg1:T32 Arg2:T75	
T76	missed_chemical 1339 1369	13-hydroxyoctadecadienoic acid
T77	missed_chemical 1371 1378	13-HODE
R15	causes_or_contributes_to Arg1:T76 Arg2:T75	
R16	causes_or_contributes_to Arg1:T77 Arg2:T75	
R17	treats Arg1:T38 Arg2:T36	
T78	corrected_chemical 1450 1463	MEK inhibitor
R18	treats Arg1:T78 Arg2:T36	
R19	treats Arg1:T41 Arg2:T40	
R20	treats Arg1:T42 Arg2:T40	
T79	missed_disease_or_phenotypic_feature 2288 2293	tumor
R21	causes_or_contributes_to Arg1:T56 Arg2:T79	
T80	corrected_chemical 2329 2344	SGLT2 inhibitor
R22	causes_or_contributes_to Arg1:T80 Arg2:T79	
T81	missed_disease_or_phenotypic_feature 2581 2593	hypertension
R23	causes_or_contributes_to Arg1:T66 Arg2:T81	
T82	missed_disease_or_phenotypic_feature 2595 2607	dyslipidemia
R24	causes_or_contributes_to Arg1:T66 Arg2:T82	
R25	causes_or_contributes_to Arg1:T66 Arg2:T65	
R26	causes_or_contributes_to Arg1:T67 Arg2:T81	
R27	causes_or_contributes_to Arg1:T67 Arg2:T82	
R28	causes_or_contributes_to Arg1:T67 Arg2:T65	
